Projects per year
Abstract
Acinetobacter baumannii is designated by the World Health Organisation as a critical priority pathogen. Previously we discovered antimicrobial peptides (AMPs), namely Lynronne-1, -2 and -3, with efficacy against bacterial pathogens, such as Staphylococcus aureus and Pseudomonas aeruginosa. Here we assessed Lynronne-1, -2 and -3 structure by circular dichroism and efficacy against clinical strains of A. baumannii. All Lynronne AMPs demonstrated alpha-helical secondary structures and had antimicrobial activity towards all tested strains of A. baumannii (Minimum Inhibitory Concentrations 2–128 μg/ml), whilst also having anti-biofilm activity. Lynronne-2 and -3 demonstrated additive effects with amoxicillin and erythromycin, and synergy with gentamicin. The AMPs demonstrated little toxicity towards mammalian cell lines or Galleria mellonella. Fluorescence-based assay data demonstrated that Lynronne-1 and -3 had higher membrane-destabilising action against A. baumannii in comparison with Lynronne-2, which was corroborated by transcriptomic analysis. For the first time, we demonstrate the therapeutic activity of Lynronne AMPs against A. baumannii.
| Original language | English |
|---|---|
| Article number | 92 |
| Number of pages | 13 |
| Journal | npj Biofilms and Microbiomes |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 30 Sept 2024 |
Keywords
- acinetobacter baumannii
- pathogen
- human health
- antimicrobial peptide
- rumen microbiome
- biofilm
- mechansim of action
Fingerprint
Dive into the research topics of 'Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Prospecting the rumen ecosystem for novel antimicrobials for animal and human health- INSTITUTIONAL LINKS
Huws, S. (Project Lead)
Centro Universitário Newton Paiva
01 Apr 2015 → 31 Mar 2017
Project: Externally funded research
-
Characterisation and exploitation of novel antimicrobials within the rumen microbiota
Huws, S. (Project Lead), McEwan, N. (Researcher Co‑Lead), Creevey, C. (Researcher Co‑Lead), Kingston-Smith, A. (Researcher Co‑Lead) & Newbold, J. (Researcher Co‑Lead)
Biotechnology and Biological Sciences Research Council
01 Apr 2014 → 31 Mar 2018
Project: Externally funded research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver